| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 313 | 6.309 | 33.269 | 54.126 | 42.232 | 67.141 | 100.455 | 135.764 | 164.001 | 172.136 |
| Total Income - EUR | 313 | 6.309 | 33.269 | 54.126 | 42.232 | 67.745 | 100.455 | 135.764 | 164.001 | 172.136 |
| Total Expenses - EUR | 27 | 14.281 | 24.628 | 32.722 | 27.687 | 35.063 | 27.228 | 34.336 | 31.469 | 30.548 |
| Gross Profit/Loss - EUR | 286 | -7.971 | 8.641 | 21.405 | 14.545 | 32.683 | 73.227 | 101.428 | 132.531 | 141.587 |
| Net Profit/Loss - EUR | 277 | -8.160 | 8.308 | 20.863 | 14.123 | 32.057 | 72.223 | 100.084 | 130.924 | 136.527 |
| Employees | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Lucident Implant Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 182 | 7.189 | 29.220 | 21.154 | 14.377 | 23.117 | 18.204 | 13.901 | 10.816 | 8.177 |
| Current Assets | 374 | 876 | 1.128 | 5.112 | 16.659 | 33.340 | 103.606 | 87.154 | 122.813 | 262.088 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 61 | 0 | 0 | 5.511 |
| Receivables | 0 | 0 | 0 | 568 | 1.428 | 8.600 | 1.377 | 83.122 | 87.550 | 135.088 |
| Cash | 374 | 876 | 1.128 | 4.545 | 15.231 | 24.739 | 102.169 | 4.032 | 35.263 | 121.489 |
| Shareholders Funds | 322 | -7.842 | 599 | 21.451 | 29.898 | 55.744 | 121.000 | 100.132 | 132.327 | 136.575 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 234 | 15.907 | 29.750 | 4.816 | 1.137 | 713 | 810 | 923 | 1.302 | 133.690 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Lucident Implant Srl